Novartis tells European MDs of Prexige measures
115886
Swiss drugmaker Novartis AG has informed doctors in Europe of new restrictions on prescribing lumiracoxib, its COX-2 inhibitor sold under the trade name Prexige, including regular liver monitoring, Britain's drug regulator said.
617687
Roche (ROG.VX: Quote, Profile, Research) has filed for EU marketing approval for its Tarceva drug to treat advanced non-small cell lung cancer, the Swiss healthcare group said on Thursday, boosting its shares.
757758
European medical regulators have called on the worldâs leading pharmaceutical companies to improve their communications with authorities and surveillance of drugs, following frustration about Merckâs handling of the withdrawal of its anti-inflammatory
667565
Novartis AG      won U.S. approval to  promote the drug Femara for women who have finished standard  therapy for early-stage breast cancer and run out of options,  the company said on Friday.
230203
Officials from Pfizer Inc, Merck & Co Inc and Novartis AG will appear next week before a panel of European drug experts, who are meeting to consider curbs on the use of COX-2 painkillers.
622280
Novartis' pain killer Prexige did not  raise the rate of serious heart problems and led to fewer ulcer  problems compared to normal anti-inflammatory drugs, results of  a study of over 18,000 patients showed.
610555
The global pharmaceutical industry unveiled plans on Thursday to publish more data about trials of medicines in a bid to reassure patients following recent alarms over drug safety.
547717
BASEL, Switzerland, August 30 /PRNewswire/ -- Novartis Pharma AG has received an &quot;approvable&quot; letter from the US Food and Drug Administration (FDA) for Certican (everolimus) in combination with Neoral (ciclosporin for microemulsion) for the prevention of
559488
Novartis AG won US approval to promote the drug Femara for women who have finished standard therapy for early-stage breast cancer and run out of options, the company said on Friday.
559136
Proposed healthcare regulation changes in the European Union could threaten UK patient care standards, say doctors. The proposed EU Services Directive is designed to ensure free movement of doctors around
369115
The European Commission has ordered a  full-scale probe into the safety of five remaining Cox-2  arthritis drugs, following last month's worldwide withdrawal of  Merck & Co Inc.'s Vioxx.
496066
Swiss pharmaceutical group Roche Holding AG on Tuesday unveiled a new method using nanotechnology to track patients' responses to treatments by monitoring their genes.
579429
Novartis AG, Switzerland s largest drugmaker, withdrew an application for European Union approval of its experimental Prexige, a painkiller similar to Merck & Co.
662969
Les donnÃ©es indiquent une augmentation de la rÃ©ponse sÃ©rologique, virologique et biochimique aprÃ¨s 144 semaines de traitement sur des patients naÃ¯fs atteints de l&#39;hÃ©patite B antigÃ¨ne positif.
432809
Pharmaceutical group Novartis on Monday  said it had received U.S. approval for Exelon Patch, which  delivers a treatment for Alzheimer&#39;s disease through a skin  patch instead of an oral capsule.
147139
Five hundred and ninety-six patients, from seven countries (Canada, Denmark, Finland, France, Norway, Sweden and the United Kingdom) were included in this retrospective analysis* of patients who originally ...
651622
Swiss pharmaceuticals group Novartis   has concluded a $500 million, 7-year global  infrastructure contract with British telecoms group BT ,  a Novartis spokesman said on Sunday.